Results

Total Results: 904 records

Showing results for "author year description".

381. Research White Paper Biorepositories Addendum Registries For Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/biorepositories-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - The consent process should involve a description of the physical risks associated with collecting the … secondary research use of identifiable private information and identifiable specimens46: • A general description … research that may be conducted with identifiable private information or identifiable biospecimens; • A description … institutions or investigators that might conduct research with such information and biospecimens; • A description … the identifiable private information or identifiable biospecimens may be stored or maintained, and a description

382. women-hiv-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
     March 01, 2016 - limit results to studies published after 01/01/2005, published in English, and having at least one author … months to be fully indexed, we will search using only free text terms for studies published in the last year

383. Methods Guide for Medical Test Reviews Chapter 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
     July 01, 2012 - For a detailed description of each included framework, the reader is referred to the original references … strategy in relation to comparator, and test-and-treat strategy in relation to clinical outcomes Description … Conflicts of interest: The author has no affiliations or financial involvement that conflicts with the … Corresponding author: Dr. David B.

384. Disposition of Comments for Treatments for Fibromyalgia in Adult Subgroups (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_disposition-comments.pdf
     January 26, 2015 - and Report): The subgroups are not further specified in the Key Questions to enable us to include author-defined … We used author-defined definitions of subgroup membership: See Appendix tables E1-E3 that detail the … Langhorst published a similar meta-anlaysis the previous year. Thank you for your feedback. … Like the rest of the document, the intro is well- written and organized, very thorough description of … On page 21 the description of the observational biofeedback study does not specify the comparator.

385. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
     September 01, 2009 - One review author extracted the…data…and the second author checked the extracted data. … The level of detail that should be included in the description of the data collection process is illustrated … PMID: 20704036 References (VII) Author This presentation was prepared by David Moher, Ph.D., director … Author

386. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Good description of why outpatient settings are more difficult to track. … One needn't be an author of a best- selling book critical of health IT (as one of the informants obviously … However, the KI interview analysis description is weak, consisting of one sentence on page 10-11. … The description of the literature review is excellent – particularly the description of the inclusion … Peer Reviewer #3 Findings The description of the findings from the literature is good.

387. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - While an accurate description of what many do, the aspirational goal is that these 1:1 personal attendants … particularly when we were unable to calculate a summary measure, we detailed the sample sizes and description … We have included this description in the Introduction of the Main Report. … We do not think that a description of beliefs is warranted in the Results section of the Main Report

388. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol-amendment.pdf
     February 05, 2025 - adolescents in the United States, with nearly 20 percent experiencing a mental health disorder in a given year … extracting descriptive data related to population and general study characteristics (e.g., first author … Five-year trends in US children's health and well-being, 2016-2020.

389. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - We have expanded the description of the two- question screen. … An abbreviated description of the quality rating process is provided in the ES. … Tables 7, 8, 10, 11, 12: Might be useful to include N and quality score in the first column after author … We have revised our description of the test characteristics studies. … differed in studies where the designer of the instrument (with or without financial incentives) was a co-author

390. Making Healthcare Safer IV Rapid Response_Active Surveillance Culturing of Clostridioides difficile and Multidrug-Resistant Organisms: Methicillin-Resistant Staphylococcus aureus, Carbapenem-Resistant Enterobacterales, and Candida auris (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
     May 01, 2024 - Comparator Usual practice or other type of PSP • No concurrent or historical comparison group • No clear description … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … Table 2: Overview of the included original studies for Review Question 5 Pathogen Author, Year Study … This report is made available to the public under the terms of a licensing agreement between the author … Risk of bias assessment for non-randomized studies Author, Year Confounding Patient Selection

391. Disposition of Comments Report for Methods for Insulin Delivery and Glucose Monitoring (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
     January 01, 2010 - Given almost one year elapsed since then AHRQ may want to consider an updated search. … We excluded all studies published prior to 1994, the year when insulin analogues were introduced. … We excluded all studies published prior to 1994, the year when insulin analogues were introduced. … We believe this title is an accurate description of what our report examines. … Methods chapter and the Methods Guide for Effectiveness and Comparative Effectiveness Reviews for a description

392. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
     October 08, 2014 - Background and Objectives for the Systematic Review Approximately 17,000 kidney transplants occur each year … conditional graft half-life (defined as the time to when half of the grafts surviving at least one year … ), and long-term follow up (more than 1 year). … ) for tacrolimus, and report on at least one analytical or patient-oriented clinical outcome (see description … of PICOTS in the background section for a description of outcomes).

393. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
     February 01, 2012 - Data Analysis We presented evidence tables and a qualitative description of results for all studies. … Results Description of Included Studies The search strategy identified 10,745 citations. … Psychotropic practice patterns for youth: a 10-year perspective.

394. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
     March 10, 2010 - In the revised version of our CER, we have included a detailed description of the methods utilized in … Four of the seven studies included here have less than 1 year follow (compared to 4-5 yearly in the

395. Disposition of Comments: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
     October 12, 2020 - field_product_pub_date https://effectivehealthcare.ahrq.gov/exit-disclaimer/ Summary of Peer Reviewer Comments and Author … effectivehealthcare.ahrq.gov/products/diverticulitis/research Published Online: October 12, 2020 4 Public Comments and Author … affect risk of recurrence or quality of life but may reduce the need for surgery over the following year … Management of Colonic Diverticulitis Comments to Draft Report Summary of Peer Reviewer Comments and Author … Response Public Comments and Author Response

396. EHC Protocol: Making Healthcare Safer IV: Opioid Stewardship (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
     July 01, 2023 - Timing • Systematic reviews published since 2019 • Original studies published since 2016, the year … Information will be organized according to the review questions, and will include author, year, study … PSP, outcomes, implementation barriers and facilitators, resources needed for implementation, and description

397. Prostate-Cancer-Test Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
     October 14, 2011 - Prostate cancer is the second most common cancer in males, accounting for 217,000 new cases per year … in the United States and causing 32,000 deaths per year.1 The disease is unpredictable. … data elements to be abstracted were established in consultation with the TEP and include: Study Description … :  Author, Year  Country  Institution type  Institutions  Enrollment period  Source … study categories Long-term Outcomes  Mortality o Overall and prostate cancer-specific o 10-year

398. Microsoft Word - ehcrr#2toCSI.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
     August 01, 2007 - ............................................................................................... 12 Author … demented patients.6 Health Canada requested that “all manufacturers of these drugs include a warning and description … To ensure a uniform 1-year eligibility period prior to filling the index APM prescription, all study … APM initiators were defined as having used no APM in the year prior to the index use. … weeks, with a modal duration of 10 weeks).6 Unadjusted and multivariable (controlling for calendar year

399. Disposition of Comments_Technical Brief No. 45: Long COVID Models of Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-disposition-comments.pdf
     January 01, 2022 - Published Online: April 30, 2024 2 Peer Reviewer, Technical Expert, and Public Comments and Author … The description of research definitions seems out of place and distracts from flow. … Creation over the past year of a standardized comprehensive multidisciplinary Post-COVID assessment … Comment: Seems inaccurate in the description of symptoms "persisting." … Peer Reviewer #2 Appendixes Page 26- Author and Year information is missing for this page of Table

400. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
     January 01, 2010 - In addition, we have provided an example of an expanded and limited screening strategy in the description … Beyond that, the Robiscek paper had moderately more rigorous statistical methodology and a better description … invasive MRSA infections in the population and 25% reduction in MRSA bacteremia in hospitals over a 5-year … Each article included in their analysis is discussed in detail, with a description of the quality of